Market Place
Sourcing Support
All News #Library
Biotech
Clearpoint Neuro Reports Third Quarter 2025 Results
06 Nov 2025 //
PHARMIWEB
Clearpoint Neuro Reveals Positive Brain Tumor Laser Therapy
07 Oct 2025 //
ACCESSWIRE
ClearPoint Neuro Expands Therapy Delivery Clearance To 34 Nations
06 Oct 2025 //
ACCESSWIRE
Clearpoint Neuro Unveils Robotic Neuro-Navigation System
01 Oct 2025 //
ACCESSWIRE
Clearpoint Neuro Names Dr. Paul Larson Chief Medical Officer
25 Sep 2025 //
ACCESSWIRE
ClearPoint Neuro Reports Milestones in Biologics, Drug Delivery
04 Aug 2025 //
ACCESSWIRE
ClearPoint Neuro Reports First Quarter 2025 Results
13 May 2025 //
ACCESSWIRE
ClearPoint Neuro Releases ClearPoint Navigation Software 3.0
24 Apr 2025 //
ACCESSWIRE
ClearPoint Neuro To Announce Q3 2024 Results On November 7
17 Oct 2024 //
GLOBENEWSWIRE
ClearPoint At ASGCT With Novel Gene Therapy Research
02 May 2024 //
GLOBENEWSWIRE
ClearPoint Neuro to Announce First Quarter 2024 Results May 7, 2024
23 Apr 2024 //
GLOBENEWSWIRE
ClearPoint Congratulates its Partner PTC of BLA Sub to FDA for Upstaza
19 Mar 2024 //
GLOBENEWSWIRE
ClearPoint Neuro Launches Proposed Public Offering of Common Stock
28 Feb 2024 //
GLOBENEWSWIRE
ClearPoint Neuro and UCB Enter License Agreement for Gene Therapy Drug Delivery
24 May 2023 //
GLOBENEWSWIRE
ClearPoint Neuro Announces Agreement with NE Scientific to Gene Therapy
18 Apr 2023 //
GLOBENEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.